CUV:ASX
Clinuvel Pharmaceuticals Ltd
A$7.55
arrow_upward
+1.75%(+0.13) 1D
Nov 11, 4:10:09 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CUV...
Open
A$7.40
High
A$7.76
Low
A$7.40
Mkt. cap
381.18M
Avg. vol.
154.28K
Volume
204.17K
Dividend
0.66%
Quarterly dividend
A$0.01
Ex-dividend date
Sep 3, 2026
P/E ratio
11.30
52-wk high
A$13.48
52-wk low
A$6.62
EPS
A$0.67
Shares outstanding
50.49M
No. of employees
16
Open
A$7.40
High
A$7.76
Low
A$7.40
Mkt. cap
381.18M
Avg. vol.
154.28K
Volume
204.17K
Dividend
0.66%
Quarterly dividend
A$0.01
Ex-dividend date
Sep 3, 2026
P/E ratio
11.30
52-wk high
A$13.48
52-wk low
A$6.62
EPS
A$0.67
Shares outstanding
50.49M
No. of employees
16
News stories
From web sources and news partners
The Detroit News
·
46 minutes ago
S&P 500, Nasdaq rise as CoreWeave results ease AI spending worries
24/7 Wall St.
·
56 minutes ago
S&P 500 Opens Up 0.8% as Nasdaq Surges and Dow Lags
Serbian News Media
·
7 hours ago
Inflation above expectations and stock decline on Wall Street
FXStreet
·
3 hours ago
AI spending fears threaten S&P 500 recovery
About Clinuvel Pharmaceuticals Ltd
CEOPhilippe J. Wolgen
Employees16
Founded1987
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteclinuvel.com